Related Experiment Videos

Clinical and angiographic determinants of initial percutaneous transluminal coronary angioplasty success

R Ilia1, D Kolanski, J Setaro

  • 1Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.

Angiology
|September 1, 1993
PubMed

Insights

Percutaneous transluminal coronary angioplasty has a high success rate. Pretreatment with aspirin may improve outcomes for patients undergoing this coronary artery procedure.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a common procedure for treating coronary artery disease.
  • Understanding factors influencing PTCA success is crucial for patient outcomes.

Purpose of the Study:

  • To retrospectively evaluate clinical and anatomic determinants of primary success in PTCA.
  • To identify patient and lesion characteristics associated with successful angioplasty.

Main Methods:

  • Retrospective analysis of 299 patients undergoing 373 PTCA procedures.
  • Evaluation of clinical factors (e.g., aspirin use, myocardial infarction) and lesion characteristics (e.g., degree of stenosis).
  • Primary success defined as residual stenosis < 50%.

Main Results:

  • Overall PTCA success rate was 94% (350/373 lesions).
  • Higher success rates were observed in patients on chronic aspirin treatment (95% vs. 86%) and those without acute myocardial infarction or postinfarction angina (96% vs. 89%).
  • Lower pre-procedure stenosis degree was associated with higher success (92.4% vs. 97.3%).

Conclusions:

  • PTCA can be performed with a high rate of primary success.
  • Chronic aspirin pretreatment may positively impact PTCA outcomes.
  • Patient referral indication (acute MI/postinfarction angina) is a significant factor affecting success.

Related Concept Videos